[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
:: Volume 16, Issue 1 (6-2022) ::
Iran J Virol 2022, 16(1): 16-21 Back to browse issues page
Evaluation of lncRNA-HULC Level in the Plasma of Chronic HCV-Infected Patients
Reihaneh Kazemi, ‪Mohammad Reza Aghasadeghi, Aras Rafiee, Fatemeh Motevalli, Mojtaba Hamidi-Fard *
Hepatitis & AIDS department, Pasteur institute of Iran, Tehran, Iran. Viral Vaccine Research Center, Pasteur Institute of Iran, Tehran, Iran.
Abstract:   (191 Views)
Background and Aims: The main role of ncRNAs (non-coding RNAs) is to regulate various cellular activities. LncRNAs (long non-coding RNAs) are a group of ncRNAs that are over 200 base pairs in length. It has been shown that lncRNAs regulate and control various cellular functions. Disruption of the expression of lncRNAs can cause various disease and deficiency in the cell function. LncRNA-HULK is one of lncRNA, which is greatly increased in liver disorders, including hepatitis C. Recently, the use of HULK as a biomarker has been suggested as a prognostic factor for liver disease such as hepatocellular carcinoma. Therefore, this study aimed to investigate the level of lncRNA-Hulk in chronic HCV-infected patients.
Materials and Methods: The present study included 50 patients with chronic hepatitis C. After transferring the samples, total RNA was extracted and the quantity of HCV-RNA and lncRNA-HULK were determined using the real-time PCR assay. Finally, the relationship between HCV-RNA and lncRNA-HULK levels was evaluated.
Results: Of the total patients, 13 were female and 37 were male. All patients were HIV Ag/Ab and HBs Ag negative. Results showed that HCV-RNA level was 4,500-2,300,000 copies per mL of plasma. In addition, threshold cycles of lncRNA-HULK were calculated 28-38. Statistical analyses showed that there was a significant relationship between HCV-RNA level and lncRNA-HULK in the plasma of chronic patients.
Conclusion: In the recent study, the relationship between HCV-RNA quantity and lncRNA-HULC level in chronic hepatitis C patients was investigated. It is suggested that lncRNA-HULC levels could be considered as a biomarker in such patients. Accordingly, lncRNA-HULC quantification could be utilized to predict the progression of liver disease and the outcome in chronic HCV-infected patients.
Keywords: non-coding RNA, lncRNA, HULC, HCV, chronic
Full-Text [PDF 536 kb]   (30 Downloads)    
Type of Study: Original article | Subject: Special
Received: 2021/06/17 | Accepted: 2021/12/4 | Published: 2022/06/20
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kazemi R, Aghasadeghi ‪ R, Rafiee A, motevalli F, Hamidi-Fard M. Evaluation of lncRNA-HULC Level in the Plasma of Chronic HCV-Infected Patients. Iran J Virol. 2022; 16 (1) :16-21
URL: http://journal.isv.org.ir/article-1-449-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 16, Issue 1 (6-2022) Back to browse issues page
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4447